TrialBritish journal of haematology2019

A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.

Shilpa Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.